Abstract
Background
Nelson’s syndrome is a rare but challenging sequelae of Cushing’s disease (CD) after bilateral adrenalectomy (BLA). We sought to determine if stereotactic radiosurgery (SRS) of residual pituitary adenoma performed before BLA can decrease the risk of Nelson’s syndrome.
Methods
Consecutive patients with CD who underwent BLA after non-curative resection of ACTH secreting pituitary adenoma and had at least one follow-up visit after BLA were studied. Nelson’s syndrome was diagnosed based on the combination of rising ACTH levels, increasing volume of the pituitary adenoma and/or hyperpigmentation.
Results
Fifty patients underwent BLA for refractory CD, and 43 patients (7 men and 36 women) had at least one follow-up visit after BAL. Median endocrine, imaging, and clinical follow-up were 66 months, 69 months, and 80 months, respectively. Nine patients (22%) were diagnosed with the Nelson’s syndrome at median time after BLA at 24 months (range: 0.6–119.4 months). SRS before BLA was associated with reduced risk of the Nelson’s syndrome (HR = 0.126; 95%CI [0.022–0.714], p=0.019), while elevated ACTH level within 6 months after BLA was associated with increased risk for the Nelson’s syndrome (HR = 9.053; 95%CI [2.076–39.472], p=0.003).
Conclusions
SRS before BLA can reduce the risk for the Nelson’s syndrome in refractory CD patients requiring BLA and should be considered before proceeding to BLA. Elevated ACTH concentration within 6 months after BLA is associated with greater risk of the Nelsons’ syndrome. When no prior SRS is administered, those with a high ACTH level shortly after BLA may benefit from early SRS.
Similar content being viewed by others
References
Assié G, Bahurel H, Bertherat J, Kujas M, Legmann P, Bertagna X (2004) The Nelson’s syndrome... revisited. Pituitary 7(4):209–215
Assié G, Bahurel H, Coste J et al (2007) Corticotroph tumor progression after adrenalectomy in Cushing’s Disease: a reappraisal of Nelson’s Syndrome. J Clin Endocrinol Metab 92(1):172–179
Barnett AH, Livesey JH, Friday K, Donald RA, Espiner EA (1983) Comparison of preoperative and postoperative ACTH concentrations after bilateral adrenalectomy in Cushing’s disease. Clin Endocrinol (Oxf) 18(3):301–305
Bunevicius A, Kano H, Lee C-C, et al (2020) Early versus late Gamma Knife radiosurgery for Cushing’s disease after prior resection: results of an international, multicenter study. J Neurosurg 1–9
Bunevicius A, Laws ER, Vance ML, Iuliano S, Sheehan J (2019) Surgical and radiosurgical treatment strategies for Cushing’s disease. J Neurooncol 145(3):403–413
Bunevicius A, Sheehan D, Lee Vance M, Schlesinger D, Sheehan JP (2020) Outcomes of Cushing’s disease following Gamma Knife radiosurgery: effect of a center’s growing experience and era of treatment. J Neurosurg 1–8
Clayton RN, Jones PW, Reulen RC et al (2016) Mortality in patients with Cushing’s disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study. Lancet Diab Endocrinol 4(7):569–576
Cordeiro D, Xu Z, Li CE, et al (2019) Gamma Knife radiosurgery for the treatment of Nelson’s syndrome: a multicenter, international study. J Neurosurg 1–6
Das L, Bhansali A, Pivonello R et al (2020) ACTH increment post total bilateral adrenalectomy for Cushing’s disease: a consistent biosignature for predicting Nelson’s syndrome. Pituitary. https://doi.org/10.1007/s11102-020-01047-x
Fountas A, Lim ES, Drake WM et al (2020) Outcomes of patients with Nelson’s syndrome after primary treatment: a multicenter study from 13 UK pituitary centers. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgz200
Gil-Cárdenas A, Herrera MF, Díaz-Polanco A, Rios JM, Pantoja JP (2007) Nelson’s syndrome after bilateral adrenalectomy for Cushing’s disease. Surgery 141(2):147–151 discussion 151-152
Hughes JD, Young WF, Chang AY, Link MJ, Garces YI, Laack NN, Thompson GB, Pollock BE (2019) Radiosurgical management of patients with persistent or recurrent cushing disease after prior transsphenoidal surgery: a management algorithm based on a 25-year experience. Neurosurgery. https://doi.org/10.1093/neuros/nyz159
Jenkins PJ, Trainer PJ, Plowman PN, Shand WS, Grossman AB, Wass JA, Besser GM (1995) The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 80(1):165–171
Katznelson L (2015) Bilateral adrenalectomy for Cushing’s disease. Pituitary 18(2):269–273
Kelly PA, Samandouras G, Grossman AB, Afshar F, Besser GM, Jenkins PJ (2002) Neurosurgical treatment of Nelson’s syndrome. J Clin Endocrinol Metab 87(12):5465–5469
Kurowska M, Nowakowski A, Zieliński G, Malicka J, Tarach JS, Maksymowicz M, Denew P (2015) Temozolomide-induced shrinkage of invasive pituitary adenoma in patient with Nelson’s syndrome: a case report and review of the literature. Case Rep Endocrinol. https://doi.org/10.1155/2015/623092
Lacroix A, Feelders RA, Stratakis CA, Nieman LK (2015) Cushing’s syndrome. The Lancet 386(9996):913–927
Lindholm J, Juul S, Jørgensen JO et al (2001) Incidence and late prognosis of cushing’s syndrome: a population-based study. J Clin Endocrinol Metab 86(1):117–123
Lüdecke DK, Breustedt HJ, Brämswig J, Köbberling J, Saeger W (1982) Evaluation of surgically treated Nelson’s syndrome. Acta Neurochir (Wien) 65(1–2):3–13
Mehta GU, Ding D, Patibandla MR et al (2017) Stereotactic radiosurgery for Cushing disease: results of an international, multicenter study. J Clin Endocrinol Metab 102(11):4284–4291
Mehta GU, Sheehan JP, Vance ML (2013) Effect of stereotactic radiosurgery before bilateral adrenalectomy for Cushing’s disease on the incidence of Nelson’s syndrome. J Neurosurg 119(6):1493–1497
Moore TJ, Dluhy RG, Williams GH, Cain JP (1976) Nelson’s syndrome: frequency, prognosis, and effect of prior pituitary irradiation. Ann Intern Med 85(6):731–734
Moyes VJ, Alusi G, Sabin HI, Evanson J, Berney DM, Kovacs K, Monson JP, Plowman PN, Drake WM (2009) Treatment of Nelson’s syndrome with temozolomide. Eur J Endocrinol 160(1):115–119
Nagesser SK, van Seters AP, Kievit J, Hermans J, Krans HM, van de Velde CJ (2000) Long-term results of total adrenalectomy for Cushing’s disease. World J Surg 24(1):108–113
Nieman LK, Biller BMK, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A (2015) Treatment of Cushing’s syndrome: an endocrine society clinical practice guideline summary of recommendations. J Clin Endocrinol Metab 100:2807–2831
Oßwald A, Plomer E, Dimopoulou C et al (2014) Favorable long-term outcomes of bilateral adrenalectomy in Cushing’s disease. Eur J Endocrinol 171(2):209–215
Palermo NE, Ananthakrishnan S (2015) Re-examining Nelson’s syndrome. Curr Opin Endocrinol Diabetes Obes 22(4):313–318
Patel J, Eloy JA, Liu JK (2015) Nelson’s syndrome: a review of the clinical manifestations, pathophysiology, and treatment strategies. Neurosurg Focus 38(2):E14
Pendharkar AV, Sussman ES, Ho AL, Hayden Gephart MG, Katznelson L (2015) Cushing’s disease: predicting long-term remission after surgical treatment. Neurosurg Focus 38(2):E13
Pereira MA, Halpern A, Salgado LR, Mendonça BB, Nery M, Liberman B, Streeten DH, Wajchenberg BL (1998) A study of patients with Nelson’s syndrome. Clin Endocrinol (Oxf) 49(4):533–539
Petersenn S, Beckers A, Ferone D et al (2015) Therapy of endocrine disease: outcomes in patients with Cushing’s disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence. Eur J Endocrinol 172(6):R227–R239
Ragnarsson O, Olsson DS, Chantzichristos D et al (2019) The incidence of Cushing’s disease: a nationwide Swedish study. Pituitary 22(2):179–186
Ritzel K, Beuschlein F, Mickisch A, Osswald A, Schneider HJ, Schopohl J, Reincke M (2013) Clinical review: outcome of bilateral adrenalectomy in Cushing’s syndrome: a systematic review. J Clin Endocrinol Metab 98(10):3939–3948
Smith PW, Turza KC, Carter CO, Vance ML, Laws ER, Hanks JB (2009) Bilateral adrenalectomy for refractory Cushing disease: a safe and definitive therapy. J Am Coll Surg 208(6):1059–1064
Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M (1996) Risk factors and long-term outcome in pituitary-dependent Cushing’s disease. J Clin Endocrinol Metab 81(7):2647–2652
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Brain Tumors
Rights and permissions
About this article
Cite this article
Bunevicius, A., Lavezzo, K., Smith, P.W. et al. Stereotactic radiosurgery before bilateral adrenalectomy is associated with lowered risk of Nelson’s syndrome in refractory Cushing’s disease patients. Acta Neurochir 163, 1949–1956 (2021). https://doi.org/10.1007/s00701-021-04823-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-021-04823-1